GRP
ALNY icon

Global Retirement Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History

Global Retirement Partners’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$570K Buy
+1,893
New +$571K 0.01% 978
2025
Q4 		$738K Buy
1,856
+1,407
+313% +$623K 0.01% 765
2025
Q3 		$205K Buy
449
+298
+197% +$121K ﹤0.01% 1169
2025
Q2 		$49.2K Buy
+151
New +$41.8K ﹤0.01% 1781
2024
Q4 		$19.1K Sell
81
-20
-20% -$5.26K ﹤0.01% 2115
2024
Q3 		$27.8K Buy
101
+48
+91% +$12.5K ﹤0.01% 1836
2024
Q2 		$12.9K Sell
53
-10
-16% -$1.58K ﹤0.01% 2202
2024
Q1 		$9.41K Sell
63
-15
-19% -$2.5K ﹤0.01% 2153
2023
Q4 		$14.6K Sell
78
-12
-13% -$2.04K ﹤0.01% 1906
2023
Q3 		$15.2K Buy
90
+5
+6% +$954 ﹤0.01% 1771
2023
Q2 		$16.1K Hold
85
– – ﹤0.01% 1761
2023
Q1 		$17K Buy
85
+8
+10% +$1.68K ﹤0.01% 1708
2022
Q4 		$18.3K Sell
77
-4
-5% -$853 ﹤0.01% 1522
2022
Q3 		$17K Sell
81
-5,179
-98% -$988K ﹤0.01% 1459
2022
Q2 		$767K Buy
5,260
+47
+0.9% +$6.67K 0.06% 281
2022
Q1 		$662K Buy
+5,213
New +$794K 0.05% 313
2021
Q4 		– Sell
-2,034
Closed -$384K – 304
2021
Q3 		$384K Buy
2,034
+62
+3% +$11.6K 0.04% 344
2021
Q2 		$334K Buy
1,972
+160
+9% +$23.4K 0.03% 362
2021
Q1 		$256K Buy
1,812
+1,728
+2,057% +$260K 0.03% 374
2020
Q4 		$11K Hold
84
– – ﹤0.01% 1219
2020
Q3 		$12K Hold
84
– – ﹤0.01% 1077
2020
Q2 		$12K Buy
84
+4
+5% +$539 ﹤0.01% 1056
2020
Q1 		$9K Hold
80
– – ﹤0.01% 1048
2019
Q4 		$9K Hold
80
– – ﹤0.01% 1165
2019
Q3 		$6K Hold
80
– – ﹤0.01% 1232
2019
Q2 		$6K Buy
+80
New +$6.14K ﹤0.01% 1227

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Global Retirement Partners's ALNY Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Alnylam Pharmaceuticals (ALNY) in Q2 2026: 1,893 shares worth $570K. The stake represents 0.01% of the portfolio and ranks #978 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in ALNY as recently as Q4 2025.

Global Retirement Partners first reported a position in ALNY in Q2 2019 and has held it in 26 quarters since. The position peaked at $767K in Q2 2022. 790 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Global Retirement Partners held 1,893 shares of Alnylam Pharmaceuticals worth $570K as of Q2 2026.
  • Alnylam Pharmaceuticals was a new Global Retirement Partners position in Q2 2026.
  • Alnylam Pharmaceuticals made up 0.01% of Global Retirement Partners's portfolio in Q2 2026, its #978 holding.
  • Global Retirement Partners first reported a position in Alnylam Pharmaceuticals in Q2 2019 and has held it in 26 quarters since.
  • Global Retirement Partners's Alnylam Pharmaceuticals position peaked at $767K in Q2 2022.
  • 790 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.